Product Description
Product Details:
- Minimum Order Quantity : 1 Box
- Packaging Size : 30
- Brand : Geftib 250 Mg Tablets
- Composition : geftinib
- Manufacturer : Glenmark
- Treatment : anti caner
- Prescription/Non prescription : Prescription
- Form : Tablet
Effective Management of NSCLCGeftib 250 mg Tablets are specifically formulated to help manage non-small cell lung cancer in adults. As an EGFR inhibitor, Gefitinib targets cancer growth at the molecular level, offering a strategic approach for those diagnosed with this cancer type. Patients should adhere to their physician's instructions to achieve optimal results and reduce health risks.
Usage and Dosage GuidelinesThis medicine is intended for oral administration, with the recommended dosage being one 250 mg tablet daily unless your physician states otherwise. It is essential to follow the prescribed schedule to maximize benefits and minimize side effects. The product is supplied in a pack of 30 tablets, ensuring a consistent routine for eligible patients.
Safety and Storage RecommendationsGeftib must be stored in a cool, dry place and kept out of the reach of children. The tablets are suitable for adult use only and require a valid prescription. Pregnant or lactating women must consult a doctor before starting treatment. Always check the expiration date before use to ensure maximum efficacy.
FAQ's of Geftib 250 mg Tablets:
Q: How should Geftib 250 mg Tablets be taken for best results?
A: Geftib 250 mg Tablets are intended for oral administration, usually once daily. It is crucial to take the medicine as directed by your physician without missing doses. Avoid altering the dosage or stopping treatment without medical supervision.
Q: What are the common side effects of Geftib 250 mg Tablets?
A: Typical side effects include rash, diarrhea, dry skin, nausea, and vomiting. Should you experience severe or persistent symptoms, contact your healthcare provider for guidance.
Q: When is Geftib 250 mg prescribed to patients?
A: This medication is prescribed to adult patients diagnosed with non-small cell lung cancer (NSCLC), particularly where targeted EGFR inhibitor therapy is appropriate as determined by a physician.
Q: What precautions should be taken before using Geftib 250 mg Tablets?
A: Pregnant or breastfeeding women should only use Geftib if expressly prescribed by a physician. Always inform your doctor about any existing medical conditions or ongoing treatments to ensure safe use.
Q: Where should Geftib 250 mg Tablets be stored?
A: Store the medication in a dry place at room temperature, away from direct sunlight and moisture. Keep the tablets securely out of children's reach.
Q: What are the benefits of using Geftib 250 mg Tablets for non-small cell lung cancer?
A: Geftib 250 mg offers a targeted approach by inhibiting EGFR, which can slow or stop the growth of cancer cells, potentially improving treatment outcomes for adults with NSCLC.